Guide destiné aux promoteurs pour la procédure synchronisée des études combinées CTR–MDR/IVDR
Safety Classified by Officially
Guidance for sponsors on the synchronised procedure for combined CTR–MDR/IVDR studies Belgium offers a synchronised submission procedure for combined studies involving medicinal products and medical devices and/or in vitro diagnostic devices. This Belgian approach aligns the timelines of both submission procedures, making it easier and more efficient for sponsors to submit their applications. …
This is an extract. The publication continues at the source.
Read the original at the source: https://www.famhp.be/fr/usage_humain/medicaments/medicaments/recherche_developpement/guide_destine_aux_promoteurs_pour_la
Officially imported this from Federal Agency for Medicines and Health Products (FAMHP)’s own source and shows an extract. If you work there, claiming the profile and verifying the domain lets you choose to show the full text here.
Provenance
- Organization
- Federal Agency for Medicines and Health Products (FAMHP) — imported from official source
- Official source
- https://www.famhp.be/en/rss.xml RSS
- Imported
- October 03, 2026 20:37
- Versions
- 1 recorded
- Identity
-
110391 at https://www.famhp.be